Category: Prescription Drugs
North America Prescription Drugs
-
Food Market Outlook 2025: Inflation, Tariffs, the Rise of Weight Loss Medications & More
... predictions and recommendations that are designed to guide retailers, wholesalers, service providers as well as food processors, packaging firms and investors in making decisions for their business about the food market. The report discusses inflation, ... Read More
-
Contract Research Organizations in the US - Industry Market Research Report
... and development investment, frustratingly high clinical trial costs and an uptick in patent expirations have driven pharmaceutical companies to outsource clinical trial management. These factors have pushed CRO revenue upward at a CAGR of 8.2% ... Read More
-
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
... Given increasing price scrutiny, competition from generics, intensifying market competition among brand-name producers and rising research and development expenses, many manufacturers have shifted their strategic focus to more lucrative therapy areas, such as rare diseases ... Read More
-
Multiple Myeloma Therapeutics
... at a CAGR of 14.5% over the analysis period 2024-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$37.6 Billion by the ... Read More
-
Medication Management Systems
... at a CAGR of 9.9% over the analysis period 2024-2030. Inventory Management Solutions, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.2 Billion by the end ... Read More
-
Cannabis Production in Canada - Industry Market Research Report
... in 2013, producers have grown continuously as they invest in production capabilities to produce quality products. As consumers shifted from illegal cannabis purchases to the licensed recreational market, cannabis growers have grown significantly, but revenue ... Read More
-
Veterinary Pain Management
... at a CAGR of 7.9% over the analysis period 2024-2030. Drugs, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.1 Billion by the end of the ... Read More
-
Sleeping Aids
... CAGR of 5.3% over the analysis period 2024-2030. Sleep Apnea Devices, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$36.9 Billion by the end of the ... Read More
-
Swine Health
... CAGR of 5.8% over the analysis period 2024-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the analysis period. ... Read More
-
Pharmaceutical Market in Canada 2025-2029
... market in canada provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Bio-pharma Logistics Market, By Type (Cold Chain Logistics and Non Cold Chain Logistics), By Service Type (Transportation, Warehousing, Packaging, and Others), By Application (Biologics, Prescribed drugs, Over-the-Counter medicines, Raw materials and bulk pharmaceuticals, and others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... and vaccines reach their intended destinations in optimal condition. With the ever-increasing global demand for pharmaceutical products, bio-pharma logistics has become an integral part of the supply chain, requiring specialized infrastructure and expertise. Market Dynamics: ... Read More
-
Orodispersible Tablets Market, By Drug Class (Analgesics, Antiemetics, Antipsychotics, Anti-inflammatory Drugs, Sedatives/Hypnotics, Antihypertensives, Others), By Disease Indication (Central Nervous System Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Respiratory Disorders, Allergy and Asthma, Others), By Age Group (Pediatric Patients, Adult Patients, Geriatric Patients), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... pediatric and geriatric patient populations who find swallowing conventional tablets difficult or uncomfortable. ODTs are formulated from various excipients including binders and disintegrants. The most common binders are methacrylic acid copolymers that have high internal ... Read More
-
Agitation in Delirium Management Market, By Drug Type (First-generation Antipsychotics, Second-generation Antipsychotics, Benzodiazepines), By Route of Administration (Oral, Intramuscular, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... exposure to certain medications, alcohol abuse, surgery or other medical procedures and factors such as exposure to toxic or infectious agents, physical trauma, diet, and other behavioral and occupational factors. There are two types of ... Read More
-
Anticonvulsant Drugs Market, by Drug Class (Barbiturates, Benzodiazepines, Aromatic allylic alcohols, Carboxamides, Triazine, AMPA receptor antagonists, Carbamate, Hydantoin, Fatty Acid Derivative, GABA analogs, Valproylamides, Others (Propionates, Oxazolidinediones, etc.)), by Route of Administration (Enteral, Parenteral), by Indication (Epilepsy, Neuropathic pain, Anxiety, Fibromyalgia, Bipolar Disorder, Others (Borderline personality disorder, etc.)), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... borderline personality disorder. Anticonvulsants, including gabapentin, carbamazepine, and valproic acid, are believed to alleviate chronic pain by obstructing sodium (valproate and the gabapentanoids) or calcium (carbamazepine and Oxcarbazepine) channels at the cellular neuronal level. This ... Read More
-
2025 North America Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS CON7975 Read More
-
2025 United States Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS CON7975 Read More
-
Rx/Reimbursement Adult Incontinence in the US
... of continuous enrolment, which officially ended in March 2023, with some states winding down disenrollment until June 2024. According to the nonprofit organisation Kaiser Family Foundation (KFF), 23 million people have been disenrolle... Euromonitor International's ... Read More
-
Canada Healthcare Distribution Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
... devices, and other healthcare-related products, ensuring that healthcare providers and patients have timely access to essential medical supplies. Factors such as increasing healthcare expenditure, the growing prevalence of chronic diseases, and the rising demand for ... Read More
-
Tranexamic Acid Market Research Report By Formulation Type (Oral Tablets, Injectable Solutions, Topical Applications), By Application (Post-Surgical Bleeding, Menorrhagia, Trauma Cases, Dental Procedures), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Clinics, Home Care Settings), By Dosage Form (Low Dosage, Standard Dosage, High Dosage) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) Industry Forecast to 2035
... to have grown from its 2024 valuation of USD 1,037.47 million to USD 1,861.99 million. The growing need for efficient hemostatic agents in pharmaceutical, cosmetic, and medical applications is propelling the global tranexamic acid market's ... Read More
-
Global Antibiotic Resistance Market, By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Others), By Disease (cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), Others (BSI (Bloodstream infection), etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
... most commonly used antibiotics include penicillin, amoxicillin, cephalosporins etc. However, over the past few decades, antibiotic resistance has been emerging as a major public health threat globally. When bacteria become antibiotic resistant, the medicines used ... Read More
-
Global Menopause Treatment Market, By Treatment Type (Hormone Therapy, Non-hormonal Therapy, Others), By Route of Administration (Oral, Topical, Parenteral, Vaginal, Others), By Form (Tablets, Creams, Patches , Pessaries, Injections, Others), By Indication (Perimenopause, Menopause, Postmenopause), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Stores, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
... Some of the most common signs and symptoms of menopause include irregular menstrual periods, hot flashes, night sweats, vaginal dryness, mood changes, and difficulty sleeping. As menopause progresses, a woman's estrogen levels drop dramatically, which ... Read More
-
Intravenous Solutions Market, by Solution (Saline (Normal Saline (0.9% NaCl) and Hypertonic Saline), Dextran, Lactated Ringers, Amino Acid, Vitamins & Minerals, Heparin and Trace Elements, and Mixed Solutions), by Bag Type (Large Volume Bags (greater than 250ml) and Small Volume Bags (less than 250ml)), by Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution), by End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Home Care Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. Dehydration ... Read More
-
Urinary Tract Infection Therapeutic Market, By Drug (Penicillin and Combinations, Quinolones, Cephalosporin, Azoles and Amphotericin B, Nitrofurans, and Other Drugs), By Indication (Complicated UTI, Uncomplicated UTI, and Other Indications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... caused by bacteria from poo entering the urinary tract. Antibiotics usually are the first treatment for urinary tract infections. Medicines commonly used for simple UTI s include Trimethoprim and sulfamethoxazole (Bactrim, Bactrim DS), Fosfomycin (Monurol), ... Read More
-
Global Inositol Market Size, Trends, By Source (Natural, Synthetic), By Application (Food & Beverages, Dietary Supplements, Pharmaceuticals, Animal Feed, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa): Global Opportunity Analysis and Industry Forecast, 2023-2030.
... Global Opportunity Analysis and Industry Forecast, 2023-2030. Global Inositol Market The Global Inositol Market was valued at US$ 130.22 Mn in 2022, estimated to reach US$ 205.05 Mn by 2030, with a CAGR of 5.66% ... Read More
-
The U.S. Weight Loss & Diet Control Market: Commercial (non-medical) Programs & Products
... hurt the most since 2022. Commercial weight loss firms lost $2 billion in sales to the GLP-1 drugs market. The business has gone virtual, and some competitors have added the GLP-1 drugs to their programs ... Read More
Research Assistance
